Dr. Edith Mirzaian is an Associate Professor of Clinical Pharmacy at the University of Southern California School of Pharmacy. She earned her Doctor of Pharmacy from the USC School of Pharmacy in 2001 and completed a residency in Community-based Pharmacy Practice in 2002. She is a Board Certified Ambulatory Care Pharmacist and holds the Certificate of Knowledge in Travel Health from the International Society of Travel Medicine. Dr. Mirzaian has served the USC Community-based Pharmacy Residency Programs in various capacities since 2005 including preceptor, site coordinator and residency program director. Dr. Mirzaian currently serves as the Assistant Dean of Curriculum at the USC School of Pharmacy, oversees the USC Community Pharmacy-based Patient Care Programs and coordinates and teaches in several courses in the Pharm.D. curriculum. Dr. Mirzaian established and served for 7 years as the Director of the USC Medication Management Center which provides health plans and PBMs solutions to exceed CMS-mandated medication therapy management (MTM) goals and improve medication adherence and patient satisfaction with MTM services. Dr. Mirzaian is a national faculty trainer for the American Pharmacists Association Pharmacy Based Immunization Training Program, Travel Health and Diabetes Care Program. She and has implemented numerous community pharmacy and clinic-based collaborative practice and patient care programs including travel health, diabetes, anticoagulation, hepatitis C, and smoking cessation clinics and multiphasic disease state screenings.
Areas of Expertise (6)
Improving STAR ratings in MTM Services in Medicare Populations
Immunizations and Vaccine-Preventable Diseases
International Travel Health
Collaborative Practice Implementation and Compensation Mechanism for Clinical Pharmacy Services
Certificate of Knowledge in Travel Health
Awarded from the International Society of Travel Medicine
University of Southern California: Pharm.D. 2001
Selected Media Appearances (3)
APhA Recognizing Professionwide Award Recipients
Edith Mirzaian, PharmD, BCACP, whose involvement in the community residency training program at the University of Southern California School of Pharmacy, is recognized by this award, which is presented to a community pharmacy residency director or preceptor who has demonstrated excellence in precepting, mentoring, leadership, and community pharmacy residency program administration...
New Hampshire Mother of 4 Dies of Flu Complications After Deciding Not to Take Tamiflu
Edith Mirzaian, an associate professor of clinical pharmacy at the University of Southern California School of Pharmacy, says Tamiflu is one of the primary medications used to treat influenza. Though it has rare adverse side effects, it has proven to be effective...
USC School of Pharmacy Selects the MirixaPro(SM) Platform
Edith Mirzaian, PharmD, Assistant Professor of Clinical Pharmacy at the USC School of Pharmacy commented, "Since the need for quality medication therapy management services has become increasingly important, we have developed a Medication Management Center to implement innovative methods of MTM delivery that provide solutions for our community. Using the MirixaPro platform will help us serve the needs of our clients effectively."...
Selected Articles (1)
Mosquito‐Borne Illnesses in Travelers: A Review of Risk and PreventionPharmacotherapy
Edith Mirzaian Pharm.D. Melissa J. Durham Pharm.D. Karl Hess Pharm.D. Jeffery A. Goad Pharm.D., M.P.H.
2012 In 2008, residents of the United States made 12 million visits to developing countries in Asia, South America, Central America, Oceania, the Middle East, and Africa. Due to the presence of Anopheles, Aedes, and Culex mosquitoes, travel to these destinations poses a risk for diseases such as malaria, yellow fever, and Japanese encephalitis that cause significant morbidity and mortality. To gain a better understanding of the major emerging and established travel‐related infectious diseases transmitted principally by mosquitoes and the measures for their prevention in U.S. residents who travel to these developing countries, we performed a literature search of the PubMed and MEDLINE databases (January 1950–February 2010). Information from the Centers for Disease Control and Prevention and the World Health Organization and relevant references from the publications identified were also reviewed. Vaccines for the prevention of Japanese encephalitis and yellow fever are commercially available to U.S. travelers and should be administered when indicated. However, the prevention of malaria, dengue fever, chikungunya, and West Nile virus relies on personal insect protection measures and chemoprophylaxis for malaria. As the rate of international travel continues to rise, individuals traveling overseas should be made aware of the risk of various infectious diseases and the importance of prevention. Physicians, pharmacists, nurses, and other practitioners can play a vital role in disease education and prevention, including the administration of vaccines and provision of chemoprophylactic drugs.